Screening criteria for breast cancer

Advances in Surgery

Volumn 44, Issue 1, 2010, Pages 87-100

  Misra, Subhasis ^a   Solomon, Naveenraj L ^a   Moffat, Frederick L ^a   Koniaris, Leonidas G ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR; ECHOGRAPHY; ECHOMAMMOGRAPHY; FEMALE; HUMAN; IMPEDANCE; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; REVIEW; RISK ASSESSMENT; BREAST NEOPLASMS;

BREAST NEOPLASMS; ELECTRIC IMPEDANCE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY; RISK ASSESSMENT; ULTRASONOGRAPHY, MAMMARY;

EID: 77956458615     PISSN: 00653411     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yasu.2010.05.008     Document Type: Review

References (56)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 2006, 56(2):106-130.
2. Bevers TB, Anderson BO, Bonaccio E, et al. Breast cancer screening and diagnosis. NCCN clinical practice guidelines in oncology. V.1.2009.
3. Berry D.A., Cronin K.A., Plevritis S.K., et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005, 353(17):1784-1792.
4. Tabar L., Vitak B., Chen H.H., et al. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001, 91(9):1724-1731.
5. Housri N., Weil R.J., Shalowitz D.I., et al. Should informed consent for cancer treatment include a discussion about hospital outcome disparities?. PLoS Med 2008, 5(10):e214.
6. Smith R.A., Saslow D., Sawyer K.A., et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003, 53(3):141-169.
7. Humphrey L.L., Helfand M., Chan B.K., et al. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002, 137(5 Part 1):347-360.
8. Seidman H., Gelb S.K., Silverberg E., et al. Survival experience in the Breast Cancer Detection Demonstration Project. CA Cancer J Clin 1987, 37(5):258-290.
9. Calonge N., Berg A.O., Allan J.D., et al. Lung cancer screening: recommendation statement. Ann Intern Med 2004, 140(9):738-739.
10. US Preventive Services Task Force Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 2009, 151(10):716-726. W-236.
11. Shapiro S., Venet W., Strax P., et al. Periodic screening for breast cancer the Health Insurance Plan Project and its sequelae, 1963-86 1988, The Johns Hopkins University Press, Baltimore (MD).
12. USPST Force Screening for breast cancer: recommendations and rationale. Ann Intern Med 2002, 137(5):3.
13. Barton M.B., Harris R., Fletcher S.W. The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How?. JAMA 1999, 282(13):1270-1280.
14. Uematsu T. Screening and diagnosis of breast cancer in augmented women. Breast Cancer 2008, 15(2):159-164.
15. Elmore J.G., Armstrong K., Lehman C.D., et al. Screening for breast cancer. JAMA 2005, 293(10):1245-1256.
16. Sumner W.E., Koniaris L.G., Snell S.E., et al. Results of 23,810 cases of ductal carcinoma-in-situ. Ann Surg Oncol 2007, 14(5):1638-1643.
17. Nakhlis F., Morrow M. Ductal carcinoma in situ. Surg Clin North Am 2003, 83(4):821-839.
18. Yang R., Cheung M.C., Hurley J., et al. A comprehensive evaluation of outcomes for inflammatory breast cancer. Breast Cancer Res Treat 2009, 117(3):631-641.
19. Burke W., Daly M., Garber J., et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 1997, 277(12):997-1003.
20. Stefanick M.L., Anderson G.L., Margolis K.L., et al. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 2006, 295(14):1647-1657.
21. Powles T.J. Anti-oestrogenic prevention of breast cancer-the make or break point. Nat Rev Cancer 2002, 2:787-794.
22. Hartmann L.C., Schaid D.J., Woods J.E., et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999, 340(2):77-84.
23. Pisano E.D., Gatsonis C.A., Yaffe M.J., et al. American College of Radiology Imaging Network digital mammographic imaging screening trial: objectives and methodology. Radiology 2005, 236(2):404-412.
24. Cunningham M.P. The Breast Cancer Detection Demonstration Project 25 years later. CA Cancer J Clin 1997, 47(3):131-133.
25. Misra S., Tarr S., Pratt D. Comparison of various breast cancer detection methods with survival rates. J Clin Oncol 2007, 25(18S):17033.
26. Gordon P.B. Ultrasound for breast cancer screening and staging. Radiol Clin North Am 2002, 40(3):431-441.
27. Stavros A.T., Thickman D., Rapp C.L., et al. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 1995, 196(1):123-134.
28. Gordon P.B., Goldenberg S.L. Malignant breast masses detected only by ultrasound. A retrospective review. Cancer 1995, 76(4):626-630.
29. Kolb T.M., Lichy J., Newhouse J.H. Occult cancer in women with dense breasts: detection with screening US-diagnostic yield and tumor characteristics. Radiology 1998, 207(1):191-199.
30. Buchberger W., DeKoekkoek-Doll P., Springer P., et al. Incidental findings on sonography of the breast: clinical significance and diagnostic workup. AJR Am J Roentgenol 1999, 173(4):921-927.
31. Kolb T.M., Lichy J., Newhouse J.H. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 2002, 225(1):165-175.
32. Berg W.A., Blume J.D., Cormack J.B., et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 2008, 299(18):2151-2163.
33. Townsend C.M., Beauchamp RD, Evers BM, et al. Diseases of the breast. Sabiston textbook of surgery 2007, Saunders Elsevier, Philadelphia.
34. Houssami N., Hayes D.F. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer?. CA Cancer J Clin 2009, 59(5):290-302.
35. Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007, 57(2):75-89.
36. Moore S.G., Shenoy P.J., Fanucchi L., et al. Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population. BMC Health Serv Res 2009, 9:9.
37. Institute NC. Improving methods for breast cancer detection and diagnosis. 2002.
38. Gail M.H., Brinton L.A., Byar D.P., et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989, 81(24):1879-1886.
39. Domchek S.M., Eisen A., Calzone K., et al. Application of breast cancer risk prediction models in clinical practice. J Clin Oncol 2003, 21(4):593-601.
40. Claus E.B., Risch N., Thompson W.D. Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 1994, 73(3):643-651.
41. Daly MB, Axilbund JE, Bryant E, et al. Genetic/familial high-risk assessment: breast and ovarian. NCCN clinical practice guidelines in oncology. V.1.2009.
42. Bevers TB, Armstrong D, Arun B, et al. Breast cancer risk reduction. NCCN clinical practice guidelines in oncology. V.2.2009.
43. American College of Radiology The ACR breast imaging reporting and data system (BI-RADS) [web source]. Available at:, Accessed September 9, 2009. http://www.acr.org/departments/stand_accred/birads/contents.html.
44. Liberman L., Menell J.H. Breast imaging reporting and data system (BI-RADS). Radiol Clin North Am 2002, 40(3):409-430. v.
45. Lacquement M.A., Mitchell D., Hollingsworth A.B. Positive predictive value of the breast imaging reporting and data system. J Am Coll Surg 1999, 189(1):34-40.
46. Orel S.G., Kay N., Reynolds C., et al. BI-RADS categorization as a predictor of malignancy. Radiology 1999, 211(3):845-850.
47. Cyrlak D., Carpenter P.M. Breast imaging case of the day. Fat necrosis of the breast. Radiographics 1999, 19(Spec No):S80-S83.
48. American Cancer Society Mammograms and other breast imaging procedures [web source]. September 30, 2009. Available at:, Accessed October 20, 2009. http://www.cancer.org/docroot/cri/content/cri_2_6x_mammography_and_other_breast_imaging_procedures_5.asp.
49. Handel N., Silverstein M.J., Gamagami P., et al. Factors affecting mammographic visualization of the breast after augmentation mammaplasty. JAMA 1992, 268(14):1913-1917.
50. Monstrey S., Christophe A., Delanghe J., et al. What exactly was wrong with the Trilucent breast implants? A unifying hypothesis. Plast Reconstr Surg 2004, 113(3):847-856.
51. Handel N., Gutierrez J. Long-term safety and efficacy of polyurethane foam-covered breast implants. Aesthet Surg J 2006, 26(3):265-274.
52. Joslyn S.A. Racial differences in treatment and survival from early-stage breast carcinoma. Cancer 2002, 95(8):1759-1766.
53. Eley J.W., Hill H.A., Chen V.W., et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 1994, 272(12):947-954.
54. Elmore J.G., Moceri V.M., Carter D., et al. Breast carcinoma tumor characteristics in black and white women. Cancer 1998, 83(12):2509-2515.
55. Furberg H., Millikan R., Dressler L., et al. Tumor characteristics in African American and white women. Breast Cancer Res Treat 2001, 68(1):33-43.
56. Yang R., Cheung M.C., Franceschi D., et al. African-American and low-socioeconomic status patients have a worse prognosis for invasive ductal and lobular breast carcinoma: do screening criteria need to change?. J Am Coll Surg 2009, 208(5):853-868. [discussion: 869-70].